← Back to Search

Implantable Device

Subcutaneous Implantable Cardioverter Defibrillator for Cardiovascular Disease (MADIT S-ICD Trial)

N/A
Waitlist Available
Led By Valentina Kutyifa, MD, MSc, PhD
Research Sponsored by Boston Scientific Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion,estimated average of 2.6 years follow-up
Awards & highlights

MADIT S-ICD Trial Summary

This trial will compare the survival rates of people with diabetes who have had a heart attack and a relatively preserved ejection fraction.

Eligible Conditions
  • Cardiovascular Disease
  • Diabetes
  • Rapid Heartbeat

MADIT S-ICD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion,estimated average of 2.6 years follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion,estimated average of 2.6 years follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
All-Cause Mortality
Secondary outcome measures
All-Cause Mortality in various subgroups
Sudden Death in various subgroups
Other outcome measures
S-ICD Inappropriate shock frequency
S-ICD Inappropriate shock outcomes
S-ICD device complications
+2 more

MADIT S-ICD Trial Design

2Treatment groups
Active Control
Group I: Conventional Medical TherapyActive Control1 Intervention
This arm of the trial continues with their current conventional medical therapy.
Group II: Subcutaneous Implantable Cardioverter DefibrillatorActive Control1 Intervention
This arm of the trial receives a subcutaneous implantable defibrillator.

Find a Location

Who is running the clinical trial?

Boston Scientific CorporationLead Sponsor
720 Previous Clinical Trials
932,982 Total Patients Enrolled
University of RochesterOTHER
840 Previous Clinical Trials
534,210 Total Patients Enrolled
Valentina Kutyifa, MD, MSc, PhDPrincipal InvestigatorUniversity of Rochester Heart Research Follow-up Program

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are investigators still looking for qualified participants?

"The clinical trial, which was first posted on April 17th, 2017, is not currently recruiting patients for participation. The last update to the study was on October 26th, 2022. Even though this particular trial is not enrolling, there are 1,753 other trials with open recruitment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator
2017. "Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02787785.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top